Cite
HARVARD Citation
De Luna, N. et al. (2018). Effect of MAPK Inhibition on the Differentiation of a Rhabdomyosarcoma Cell Line Combined With CRISPR/Cas9 Technology: An In Vitro Model of Human Muscle Diseases. Journal of neuropathology and experimental neurology. 77 (10), pp. 964-972. [Online].